The Enterprise Value as of June 2026 (TTM) for Arbutus Biopharma Corporation (ABUS) is 818.44M

According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 818.44M. This represents a change of 3.55% compared to the average of 790.35M of the last 4 quarters.

Arbutus Biopharma Corporation (ABUS) Historical Enterprise Value (quarterly & annually)

How has ABUS Enterprise Value performed in the past?

The mean historical Enterprise Value of Arbutus Biopharma Corporation over the last ten years is 343.05M. The current 818.44M Enterprise Value has changed 23.76% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Enterprise Value was at its highest in in the December 2025 quarter at 907.77M. The Enterprise Value was at its lowest in in the September 2019 quarter at 370.76K.

Arbutus Biopharma Corporation (ABUS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arbutus Biopharma Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arbutus Biopharma Corporation (ABUS) Average Enterprise Value

How has ABUS Enterprise Value performed in the past?

The current Enterprise Value of Arbutus Biopharma Corporation (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arbutus Biopharma Corporation (ABUS) Enterprise Value vs. Peers

How is ABUS’s Enterprise Value compared to its peers?

Arbutus Biopharma Corporation’s Enterprise Value is less than ARS Pharmaceuticals, Inc. (1.04B), less than Nanobiotix S.A. (1.60B), less than GH Research PLC (1.21B), less than Tango Therapeutics, Inc. (3.73B), less than Bicara Therapeutics Inc. Common Stock (866.15M), less than Septerna, Inc. (1.57B), less than EyePoint Pharmaceuticals, Inc. (1.03B), greater than Kura Oncology, Inc. (788.60M), less than ProKidney Corp. (1.15B), less than Savara Inc. (1.07B),

Build a custom stock screener for Arbutus Biopharma Corporation (ABUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arbutus Biopharma Corporation (ABUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.